About Careers MedBlog Contact us

Creatine Monohydrate Supplementation Does Not Slow Progression of Parkinson's Disease

by Dr. Trupti Shirole on February 11, 2015 at 7:12 PM
Font : A-A+

 Creatine Monohydrate Supplementation Does Not Slow Progression of Parkinson's Disease

Treatment of Parkinson's disease patients with creatine monohydrate, compared with placebo, for at least 5-years in early and treated cases has failed to slow clinical progression of the disease, revealed researchers of the University of Rochester, Rochester, N.Y. The study findings do not support the use of creatine monohydrate in patients with Parkinson disease.

Parkinson's disease is a progressive neurodegenerative disorder that affects approximately 6 million people worldwide and more than 1.5 million individuals in the United States, and its incidence is expected to increase over the next decade. There is neither a cure nor a treatment that has been proven to slow progression of the disease. Previous study evidence indicates that creatine, an amino acid, plays an important role in cellular energy production, which may be impaired in Parkinson disease; and oral creatine supplementation in mice has suggested a neuroprotective effect.


Researchers randomly assigned 1,741 men and women with early (within 5 years of diagnosis) and treated (receiving dopaminergic therapy) Parkinson disease to receive placebo or creatine monohydrate (10 g/d) for a minimum of 5 years (maximum follow-up, 8 years). Using several measures of Parkinson disease progression, the researchers found that treatment with creatine monohydrate, compared with placebo, did not improve clinical outcomes.

The study is published in 'JAMA'.

Source: Medindia


Recommended Reading

Latest Research News

 Blind People Feel Their Heartbeat Better Than Those With Sight
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
New Biomarkers Help Detect Alzheimer's Disease Early
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.
Bone Health and Dementia: Establishing a Link
Is there a connection between Osteoporosis and dementia? Yes, loss in bone density may be linked to an increased risk of dementia in older age.
Is Telomere Shortening a Sign of Cellular Aging?
Link between chromosome length and biological aging marker discovered. The finding helps explain why people with longer telomeres have a lower dementia risk.
Why Is Integrated Structural Biology Important for Cystic Fibrosis?
Integrated structural biology helps discover how the cystic fibrosis transmembrane conductance regulator (CFTR) works.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Creatine Monohydrate Supplementation Does Not Slow Progression of Parkinson's Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests